Premium
Mechanisms for the Specific Properties of γ‐Hydroxybutyrate in Brain
Author(s) -
Maitre Michel,
Klein Christian,
MensahNyagan Ayikoe G.
Publication year - 2016
Publication title -
medicinal research reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.868
H-Index - 130
eISSN - 1098-1128
pISSN - 0198-6325
DOI - 10.1002/med.21382
Subject(s) - drug , gabaergic , mechanism of action , addiction , neuroscience , gamma hydroxybutyrate , pharmacology , mechanism (biology) , medicine , psychology , chemistry , inhibitory postsynaptic potential , biochemistry , in vitro , philosophy , epistemology
γ‐Hydroxybutyrate (GHB) is both a natural brain compound with neuromodulatory properties at central GABAergic synapses (micromolar concentration range) and also a drug (Xyrem R ) clinically used for the treatment of various neurological symptoms (millimolar dose range). However, this drug has abuse potential and can be addictive for some patients. Here, we review the basic mechanistic role of endogenous GHB in brain as well as the properties and mechanisms of action for therapeutic clinical doses of exogenous GHB. Several hypotheses are discussed with a preference for a molecular mechanism that conciliates most of the findings available. This conciliatory model may help for the design of GHB‐like drugs active at lower doses and devoid of major side effects.